BioSpace News Archive

Drug Development

Ocugen Initiates Phase 3 Clinical Trial of OCU310 for Dry Eye Disease

Ocugen, Inc. today announced that it has initiated a Phase 3 clinical trial for its second lead product candidate, OCU310 for patients with dry eye disease (DED).

October 1, 2018
·
3 min read
Business

Manitex Capital Inc. Announces That Its Affiliate Valeo Pharma Inc. Has Filed a Non-Offering Preliminary Prospectus

Manitex Capital Inc. is pleased to announce that its affiliate, Valeo Pharma Inc., has filed a non-offering preliminary prospectus with the securities regulatory authorities of all provinces and territories in Canada.

October 1, 2018
·
2 min read
Policy

Health Canada approves TRESIBA® for children with Type 1 diabetes

Rates of Type 1 diabetes among children and youth on the rise globally

October 1, 2018
·
4 min read
Drug Development

Torque Announces the Presentation of Preclinical Data for Deep IL-15 Primed T Cells Demonstrating Superior T Cell Expansion, Persistence, and Safety Compared with Systemically Administered IL-15

Torque announced today preclinical data demonstrating superior T cell expansion, persistence, and safety for the company’s Deep IL-15 Primed T cells compared to systemically administered IL-15.

October 1, 2018
·
4 min read
Business

Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 24, 2018

Thermo Fisher Scientific Inc., announced that it will release its financial results for the third quarter before the market opens on Wednesday, October 24, 2018, and will hold a conference call on the same day at 8:30 a.m. EDT.

October 1, 2018
·
1 min read
Business

PharmaFluidics Facilitates Ultra-High-Resolution Proteomics Analysis Through Agreement With Thermo Fisher Scientific

The agreement will allow bio-analysis customers to simplify workflows and improve the analytical performance of their HPLC-MS systems

October 1, 2018
·
3 min read
Drug Development

Presentation at International IgA Nephropathy Network Meeting Highlighting Supportive Post-hoc Analysis of the NEFIGAN Study

Calliditas Therapeutics AB today announced supportive post-hoc results from its clinical Phase 2b study NEFIGAN of the company’s lead candidate Nefecon, presented by Prof. Bengt Fellström at the International IgA Nephropathy Network meeting (IIgANN) in Buenos Aires, Argentina, on September 28, 2018.

October 1, 2018
·
5 min read
Forbion Closes Oversubscribed Fourth Life Sciences VC Fund at EUR 360 million

Investment focus is on new drugs and technologies that will truly impact the future of medicine

October 1, 2018
·
3 min read
Zecotek Commences Manufacture of Solid-state Photo Diodes and Transistors and Targets Emerging Industries of Self-Driving Autos, Agriculture and Genomics

Zecotek Photonics Inc. is pleased to announce that it has initiated the manufacturing of its new generation series of solid-state micro-pixel avalanche photo diodes and transistors (MAPD/T) at the Malaysian Institute of Microelectronics Systems.

October 1, 2018
·
5 min read
Business

Pfizer Announces CEO Succession

Effective January 1, 2019, Dr. Albert Bourla to become Chief Executive Officer (CEO) and Ian Read to serve as Executive Chairman of the Board of Directors

October 1, 2018
·
7 min read